Noncompliance With Congestive Heart Failure Therapy in the Elderly

Archives of Internal Medicine

Volumn 154, Issue 4, 1994, Pages 433-437

  Monane, Mark ^a,b   Bohn, Rhonda L ^a,b   Gurwitz, Jerry H ^a,b   Glynn, Robert J ^a,b   Avorn, Jerry ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN;

AGED; ARTICLE; CONGESTIVE HEART FAILURE; FEMALE; GERIATRIC PATIENT; HUMAN; LONG TERM CARE; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DIGOXIN; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICAID; NEW JERSEY; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; TREATMENT REFUSAL; UNITED STATES;

EID: 0028323337     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1994.00420040107014     Document Type: Article

References (34)

1. Sackett DL, Snow JC. The magnitude of compliance and noncompliance. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Md: The Johns Hopkins University Press; 1979:11-23.
2. Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med. 1984;100:258-268.
3. Darnell JC, Murray MD, Martz BL, Weinberger M. Medication use by ambulatory elderly: an in-home survey. J Am Geriatr Soc. 1986;34:1-4.
4. German PS, Klein LE, McPhee SJ, Smith CR. Knowledge of and compliance with drug regimens in the elderly. J Am Geriatr Soc. 1982;30:568-571.
5. Everitt DE, Avorn J. Drug prescribing for the elderly. Arch Intern Med. 1986; 146:2393-2396.
6. Stewart RB, Caranasos GJ. Medication compliance in the elderly. Med Clin North Am. 1989;73:1551-1563.
7. Hale WE, Perkins LL, May FE, Marks RG, Stewart RB. Symptom prevalence in the elderly: an evaluation of age, sex, disease, and medication use. J Am Geriatr Soc. 1986;34:333-340.
8. Nolan L, O’Malley K. Prescribing for the elderly, II: prescribing patterns: differences due to age. J Am Geriatr Soc. 1988;36:245-254.
9. Haynes RB. Determinants of compliance: the disease and the mechanics of treatment. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Md: The Johns Hopkins University Press; 1979:49-62.
10. Wei JY, Gersh BJ. Heart disease in the elderly. Curr Probl Cardiol. 1987;12:1-65.
11. Rahimtoola SH. The pharmacologic treatment of chronic congestive heart failure. Circulation. 1989;80:693-699.
12. The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA. 1988;259:539-544.
13. Guyatt GH, Sullivan MJ, Fallen EL, et al. A controlled trial of digoxin in congestive heart failure. Am J Cardiol. 1988;61:371-375.
14. Sullivan M, Atwood JE, Myers J, et al. Increased exercise capacity after digoxin administration in patients with heart failure. JAm Coll Cardiol. 1989;13:1138-1143.
15. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989;320:677-683.
16. Gheorghiade M, Hall V, Lakier JB, Goldstein S. Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll Cardiol. 1989;13:134-142.
17. Kulick DL, Rahimtoola SH. Current role of digitalis therapy in patients with congestive heart failure. JAMA. 1991;265:2995-2997.
18. Fletcher SW, Pappius EM, Harper SJ. Measurement of medication compliance in a clinical setting: comparison of three methods in patients prescribed digoxin. Arch Intern Med. 1979;139:635-638.
19. Johnston GD, Kelly JG, McDevitt DG. Do patients take digoxin? Br Heart J. 1978;40:1-7.
20. Wiseman IC, Miller R. Quantifying non-compliance in patients receiving digoxin: a pharmacokinetic approach. S Afr Med J. 1991;79:155-157.
21. Grauer K, Curry RW, Robinson JD. Prediction of serum concentrations of digoxin in a family practice center. J Fam Pract. 1982;15:1081-1086.
22. Federspiel CF, Ray WA, Schaffner W. Medicaid records as a valid data source: the Tennessee experience. Med Care. 1976;14:166-172.
23. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach: a randomized controlled trial of academically-based ‘detailing.’ N Engl J Med 1983;308:1457-1463.
24. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus? Ann Intern Med. 1993;118:273-278.
25. Gurwitz JH, Glynn RJ, Monane M, et al. The high prevalence of nonadherence among elderly patients starting therapy for glaucoma. Am J Public Health. 1993; 83:711-716.
26. Drug Facts and Comparisons: 1991 Edition. St Louis, Mo: JB Lippincott Co; 1991.
27. American Medical Association. AMA Drug Evaluations. Chicago, III: American Medical Association; 1991.
28. SAS Institute Inc. SAS User’s Guide: Statistics, Version 5 Edition. Cary, NC: SAS Institute Inc; 1985.
29. Francis CK. Hypertension, cardiac disease, and compliance in minority patients. Am J Med. 1991;91(suppl 1A):29S-35S.
30. Kirkman-Liff B, Mondragon D. Language of interview: relevance for research of southwest Hispanics. Am J Public Health. 1991;81:1399-1404.
31. Council on Scientific Affairs. Hispanic health in the United States. JAMA. 1991; 265:248-252.
32. Kass MA, Gordon M, Morley RE, Meltzer DW, Goldberg JJ. Compliance with topical timolol treatment. Am J Ophthalmol. 1987;103:188-193.
33. Lessler JT, Harris BSH. Medicaid Data as a Source for Postmarketing Surveillance Information: Final Report, Volume I: Technical Report. Research Triangle Park, NC: Research Triangle Institute; 1984.
34. US Senate. Special Committee on Aging. Prescription Drugs and the Elderly: The High Cost of Growing Old, 1987. Washington, DC: Government Printing Office; 1990.